10.90 USD
↗ 0.54 (5.21%)AT CLOSE (11:59 AM EDT)
Kura Oncology, Inc.
KURANASDAQ • USD
10.98
↗ 0.08 (0.70%)
POST MARKET (AS OF 07:32 PM EDT)
Post Market
AS OF 07:32 PM EDT
10.98
↗ 0.08 (0.70%)
Market: CLOSED
Shares of Kura Oncology, Inc. (KURA) are trading at $10.90. KURA shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 26, 2026.
Open?$10.27
High?$11.05
Low?$10.15
Prev. Close?$10.36
Volume?5.3M
Avg. Volume?2.1M
VWAP?$10.67
Rel. Volume?2.47x
Bid / Ask
Bid?$8.60 × 100
Ask?$12.77 × 100
Spread?$4.17
Midpoint?$10.68
Valuation & Ratios
Market Cap?967.6M
Shares Out?88.8M
Float?78.1M
Float %?87.9%
P/E Ratio?N/A
P/B Ratio?8.97
EPS?-$3.32
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
Employees
260
Market Cap
919.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-08-25
Address
4930 DIRECTORS PLACE, SUITE 500
SAN DIEGO, CA 92121
Phone: (858) 500-8800
SAN DIEGO, CA 92121
Phone: (858) 500-8800
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?27
Short Sent.?20
Piotroski F-Score?2/9Weak
Altman Z-Score?-2.15Distress
Confidence?71%Moderate
Short InterestHigh
Short % of Float?18.71%High
Short Interest?14.6M
Days to Cover?7.3
Free Float78.1M
Avg Daily Volume2.0M
Settlement Date2026-06-15
Financial Health
Current Ratio?6.15Strong
Quick Ratio?6.14Strong
Cash Ratio?0.39Low
Debt/Equity?0.09Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?8.97HIGH▾
Peers100
S&P21
P/S?13.51HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.0CHEAP▾
S&P97
EV/Sales?13.10HIGH▾
Peers100
S&P6
Returns & Efficiency
ROE?-273.1%WEAK▾
S&P3
ROA?-45.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-84459000
Enterprise Value?$938.3M
Fundamentals ratios updated end of day